Akebia Therapeutics, Inc. (AKBA)
1.06
-0.07
(-6.19%)
USD |
NASDAQ |
May 15, 16:00
1.08
+0.02
(+1.89%)
After-Hours: 07:17
Akebia Therapeutics EPS Diluted (Quarterly) : -0.0339 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| MannKind Corp. | -0.0539 |
| United Therapeutics Corp. | 5.824 |
| Ardelyx, Inc. | -0.153 |
| Rhythm Pharmaceuticals, Inc. | -0.8348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.054M |
| Revenue (Quarterly) | 53.54M |
| Total Expenses (Quarterly) | 62.60M |
| Enterprise Value | 337.93M |
| Gross Profit Margin (Quarterly) | 76.43% |
| Profit Margin (Quarterly) | -16.91% |
| Earnings Yield | -7.27% |
| Operating Earnings Yield | 1.85% |
| Normalized Earnings Yield | -6.604 |